Results 41 to 50 of about 71,065 (294)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation

open access: yesChemical Science, 2018
Prodrug–prodrug activation describes the simultaneous, traceless and bioorthogonal activation of two drugs.
Kevin Neumann   +3 more
openaire   +4 more sources

Prodrugs for Amines [PDF]

open access: yesMolecules, 2008
The purpose of this work is to review the published strategies for the productionof prodrugs of amines. The review is divided in two main groups of approaches: those thatrely on enzymatic activation and those that take advantage of physiological chemicalconditions for release of the drugs.
John F. Gilmer   +2 more
openaire   +3 more sources

Prodrug-Based Cascade Self-Assembly Strategy for Precisely Controlled Combination Drug Therapy

open access: yes, 2018
The development of codelivery systems for combination therapy that can load different drugs in a single carrier and precisely deliver payloads (ratio and administration time) via programmable administration has proven to be challenging.
Wei Ha (836306)   +4 more
core   +1 more source

Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy

open access: yesJournal of Functional Biomaterials, 2019
Directed enzyme prodrug therapy (DEPT) involves the delivery of a prodrug-activating enzyme to a solid tumour site, followed by the subsequent activation of an administered prodrug.
Simon D. Anderson   +6 more
doaj   +1 more source

Polymeric Nanovectors Incorporated with Ganciclovir and HSV-tk Encoding Plasmid for Gene-Directed Enzyme Prodrug Therapy

open access: yesMolecules, 2021
In the area of gene-directed enzyme prodrug therapy (GDEPT), using herpes simplex virus thymidine kinase (HSV-tk) paired with prodrug ganciclovir (GCV) for cancer treatment has been extensively studied. It is a process involved with two steps whereby the
Alicia J. Sawdon   +4 more
doaj   +1 more source

Conditions for safe and effective ADEPT treatment [PDF]

open access: yes, 2010
Antibody directed enzyme prodrug therapy (ADEPT) is a drug delivery system developed for the treatment of cancer. ADEPT uses a systemically administered antibody, tethered to an enzyme, to localize enzyme in tumour deposits.
Wilkins, D.K.
core  

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

open access: yesFEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová   +2 more
wiley   +1 more source

Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach

open access: yesPharmaceutics, 2019
Using thyrotropin-releasing hormone (TRH) as a model, we explored whether synergistic combination of lipoamino acid(s) and a linker cleaved by prolyl oligopeptidase (POP) can be used as a promoiety for prodrug design for the preferential brain delivery ...
Katalin Prokai-Tatrai   +5 more
doaj   +1 more source

Electrodrugs: An electrochemical prodrug activation strategy

open access: yes, 2018
Dataset corresponding to manuscript entitled "Electrodrugs: an electrochemical prodrug activation strategy"
Murray, Alan   +7 more
core   +1 more source

A prodrug activated by H2O2 and mitochondrial hydroxide: an improvement of cancer cells versus neutrophils selectivity [PDF]

open access: yes, 2023
Many known chemotherapeutic anticancer agents exhibit neutropenia as a dose-limiting side effect. In this paper we suggest a prodrug concept solving this problem for camptothecin (HO-cpt). The prodrug is programmed according to Boolean “AND” logic.
Tina, Jost   +18 more
core   +2 more sources

Home - About - Disclaimer - Privacy